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AIM 
 
1. To study and compare the relationship of PaCO2- EtCO2 gradient 
between pre cardio pulmonary bypass and post cardio pulmonary 
bypass period. 
 
2.  To find out if any factor affects this gradient. 
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INTRODUCTION 
Knowledge and control of arterial CO2 is an essential part of anaesthesia 
especially during cardiac surgery. To determine the adequacy of alveolar 
ventilation it is important to know PaCO2. Capnography constitutes a useful and 
non invasive means of continuously measuring EtCO2 which usually correlates 
with PaCO2. In normal individuals the arterial- End tidal CO2 difference (PaCO2-
EtCO2 gradient) may vary from 2-5 mm Hg1-5. But several factors like 
hypotension, decrease in pulmonary blood flow can result in alteration in 
ventilation-perfusion ratio. This in turn, alters the alveolar dead space and affects 
arterial- alveolar CO2 difference. During cardio pulmonary bypass there is 
considerable alterations in ventilation-perfusion ratio and alveolar dead space 
which may extend into the post cardio pulmonary bypass period. It is important to 
know the PaCO2-EtCO2 gradient variation during cardiac surgery and identify the 
factors causing this variation. Hence we decided to study the Arterial – End tidal 
CO2 gradient in the pre cardio pulmonary bypass period and compare it to the 
post cardio pulmonary bypass period in patients undergoing coronary artery 
bypass graft. 
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LITERATURE REVIEW 
             Capnography has become an integral part of monitoring the patient 
intraoperatively. During anesthesia, capnography directly reflects the elimination 
of CO2 by the lungs. Indirectly, it reflects the production of CO2 by tissues and the 
circulatory transport of CO2 to the lungs. Thus capnography is an important non-
invasive technique that provides information about CO2 production, pulmonary 
perfusion and alveolar ventilation, respiratory patterns as well as elimination of 
CO2 by the lungs. 
PHYSIOLOGY: 
At the end of inspiration, assuming that there is no rebreathing, the airway 
and the lungs are filled with CO2-free gases. Carbon dioxide diffuses into the 
alveoli and equilibrates with the end-alveolar capillary blood (PACO2 = PaCO2 = 
40 mm Hg). The actual concentration of CO2 in the alveoli is determined by the 
extent of ventilation and perfusion into the alveoli (V/Q ratio).   The alveoli with 
higher ventilation in relation to perfusion (high V/Q alveoli) have lower 
CO2 compared to alveoli with low V/Q ratio that would have higher CO2.  As one 
moves proximally in the respiratory tract, the concentration of CO2 falls gradually 
to zero at some point.  The volume of CO2-free gas is termed respiratory dead 
space and here there is no exchange of oxygen (O2) and CO2 between the 
inspired gases and the blood.  As the patient exhales, a CO2 sensor at the mouth 
will detect no CO2 as the initial gas sampled will be the CO2-free gas from the 
dead space.  As exhalation continues, CO2 concentration rises gradually and 
reaches a peak as the CO2 rich gases from the alveoli make their way to the CO2 
sensing point at the mouth. At the end of exhalation, the CO2 concentration 
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decreases to zero (baseline) as the patient commences inhalation of CO2 free 
gases. The evolution of CO2 from the alveoli to the mouth during exhalation, and 
inhalation of CO2 free gases during inspiration gives the characteristic shape to 
the CO2 curve which is identical in all humans with healthy lungs.1 Any deviation 
from this identical shape should be investigated to determine a physiological or a 
pathological cause producing the abnormality. 
• A typical time capnogram  can be considered as two segments and two 
angles; an inspiratory segment and an expiratory segment, and alpha and 
beta angles.2,3 
 
 
 
Expiratory segment 
The expiratory segment of a time capnogram is divided into three phases: I, II, 
III.  Occasionally, at the end of phase III, a terminal upswing, phase IV, may 
occur.  
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Phase I        
Represents the CO2-free gas from the airways (anatomical and apparatus dead 
space). 
Phase II       
Consists of a rapid S-shaped upswing on the tracing (due to mixing of dead 
space gas with alveolar gas). 
Phase III       
Consists of an alveolar plateau representing CO2-rich gas from the alveoli. It 
almost always has a positive slope, indicating a rising PCO2 and is due to the 
following reasons: 
(ii) Steady excretion of CO2 into the alveoli 
Carbon dioxide is being continuously excreted into the alveoli which are 
becoming progressively smaller as expiration continues.  This results in a 
steady increase in alveolar PCO2 towards the end of expiration, and 
hence contributes to a rising positive slope of phase III as expiration 
proceeds. 
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(ii) The late emptying of alveoli with lower ventilation/perfusion (V/Q) 
ratios and, therefore, relatively higher PC02.  
If all the alveoli had the same PC02, then irrespective of the emptying 
patterns, phase III would be nearly horizontal. However, this ideal situation does 
not occur, even in normal lungs which have a wide range of V/Q ratios. Some 
alveoli have a higher V/Q ratio (over ventilated) than ideal alveoli and hence they 
have a relatively lower PC02. Others have a lower V/Q ratio than ideal alveoli 
(under ventilated) resulting in a relatively higher PC02. The delayed emptying of 
these alveoli with low V/Q (high PC02) contributes to the rising slope of phase III. 
The mechanisms producing this effect are:-4, 5  
(A) Within the terminal respiratory unit 
 Ventilation:perfusion (V/Q) mismatch within the unit may be due either to 
incomplete gas mixing (alveolar mixing defect) or to the fact that the maximum 
ventilation and maximum perfusion to that unit are out of sequence in respect to 
time (temporal mismatching - perfusion is highest during the latter part of 
expiration when ventilation is lowest). The scatter of V/Q ratios produced as a 
result is axially distributed with those alveoli having low V/Q ratio (higher PC02) 
being distributed distally and emptying later. 
(B) Between respiratory units  
There may be a regional variation in ventilation per unit perfusion 
producing a spectrum of V/Q ratios (spatial mismatching). Under these 
circumstances, the slope of phase III is determined by the nature of emptying of 
the alveolar units: synchronous or asynchronous. If the units empty 
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synchronously, the gas from well-perfused and underperfused alveoli is expired 
simultaneously, resulting in a horizontal phase III or else a phase III with minimal 
slope. However, if the units empty asynchronously, units with longer time 
constants, hence higher PC02, would empty later (sequential emptying) resulting 
in a rising slope of Phase III.  The slope of the phase III is dependent, therefore, 
on the emptying patterns of various alveoli with different V/Q ratios as well as 
continuous C02 excretion into the alveoli. The relative contributions of all of the 
above mechanisms cannot be separated and all occur simultaneously, 
influencing the height or the slope of phase III. Factors, such as changes in 
cardiac output, CO2 production, airway resistance and functional residual 
capacity (FRC) may further affect the V/Q status of the various units in the lung, 
and thus influence the height or the slope of phase III. This attribute makes 
capnography a useful diagnostic tool to detect abnormalities in ventilation 
perfusion mismatch of the lung. 
Inspiratory segment - Phase 0  
After phase III is complete, the descending limb makes an almost right 
angle turn and rapidly descends to the baseline.  This represents the inspiratory 
phase during which the fresh gases (CO2 -free gases) are inhaled and CO2 
concentration falls rapidly  to zero.2,3 The segment of the CO2 trace from the 
beginning of inspiration to the beginning of expiration, which includes the 
descending limb and the initial part of the horizontal baseline, can be designated 
as phase 0.  The later part of the horizontal baseline is the phase I of expiratory 
segment.  Phase 0 represents dynamics of inspiration. 
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Alfa Angle 
The angle between phases 11 and III, which has been referred to as the 
alpha angle, increases as the slope of phase III increases. The alpha angle 
(primarily linked to variations in time constants within the lung) is thus an indirect 
indication of V/Q status of the lung.6 
Beta Angle    
The nearly 90 degrees angle between phase III and the descending limb in 
a time capnogram has been termed as the beta angle.7  This can be used to 
assess the extent of rebreathing.7   During rebreathing, there is an increase in 
beta angle from the normal 90 degrees.  As rebreathing increases, the horizontal 
baseline of phase 0 and phase I can be elevated above normal.7 Occasionally, 
other factors, such as prolonged response time of the capnometer compared to 
respiratory cycle time of the patient, particularly in children, can produce increase 
in the beta angle with the elevation of the baseline of phase 0 and phase I, as 
observed in rebreathing.8 
PEtCO2 as a measure of PaCO2 
Measurement of End tidal carbon dioxide constitutes the useful non-
invasive measurement of monitoring PaCO2 and hence the ventilatory status of 
the patient during anaesthesia. 
The advantages of capnography as a measure of PaCO2 are: 
(1) It provides continuous estimate of PaCO2. 
(2) It gives an instantaneous estimate of PaCO2. 
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(3) After the initial capital expense of purchasing the equipment it is 
inexpensive to use. 
In a study comparing PaCO2 and PEtCO2 during anaesthesia, the 
difference between these values correlated with the presence of 
lung disease, age, ASA class and systolic blood pressure. 
But other studies have shown that changes in PaCO2 were 
inaccurately predicted by PEtCO2. 
In summary, the disadvantage of using EtCO2 to estimate PaCO2 is 
that there is an arterial to end tidal CO2 difference which is 
dependent on various factors.9-12  
P (a-ET) CO2 gradient  
Under normal circumstances, the PETCO2 (the CO2 recorded at the end of the 
breath which represents PCO2 from alveoli which empty last) is lower than 
PaCO2 (average of all alveoli) by 2-5 mmHg, in adults.1-5, 13, 14 The (a-ET) 
(arterial- End tidal) PCO2 gradient is due to the V/Q mismatch in the lungs 
(alveolar dead space) as a result of temporal, spatial, and alveolar mixing 
defects.  In healthy children, the (a-ET)PCO2 gradient is smaller (-0.65-3 mm Hg) 
than in adults.14-19 This is due to a better V/Q matching, and hence a lower 
alveolar dead space in children than in the adults.9  The (a-ET)PCO2 / PaCO2  
fraction is a measure of alveolar dead space, and  changes in  alveolar dead 
space correlate well with changes in (a-ET)PCO2.5   An increase in (a-ET)PCO2  
suggests an increase in dead space ventilation.  Hence (a-ET) PCO2 is an 
indirect estimate of V/Q mismatching of the lung. 
 
 
13
However, (a-ET) PCO2 does not correlate with alveolar dead space in all 
circumstances. Changes in alveolar dead space correlate with (a-ET) PCO2 only 
when phase III is flat or has a minimal slope.  However, if phase III has a steeper 
slope, the terminal part of phase III may intercept the line representing PaCO2, 
resulting in either zero or negative (a-ET)PCO2 even in the presence of alveolar 
dead space.  Therefore, the (a-ET) PCO2 is dependent both on alveolar dead 
space as well as factors that influence the slope of phase III. This implies that an 
increase in the alveolar dead space need not be always being associated with an 
increase in the (a-ET) PCO2. The (a-ET) PCO2 may remain the same if there is an 
associated increase in the slope of the phase III.  For example, it has been 
observed during cardiac surgery that alveolar dead space was increased at the 
end of cardiopulmonary bypass but as the slope of phase III was also increased, 
there was no change in (a-ET) PCO2.21, 22 
Factors affecting (a-Et) PCO2 
           This difference can vary from patient to patient and is dependent on 
various factors. (a-ET)PCO2 increases with age, emphysema, and in 
circumstances where alveolar dead space increases such as in low cardiac 
output states, hypovolemia, and pulmonary embolism and anaesthesia itself. The 
difference increases with large tidal volumes and low frequency ventilation. 
Cardiac output and (a-ET) PCO2  
Reduction in cardiac output and pulmonary blood flow result in a decrease 
in PETCO2 and an increase in (a-ET)PC02.23,24 The percent decrease in 
PETCO2  directly correlated with the percent decrease in cardiac output (slope= 
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0.33, r2=0.82 in 24 patients undergoing aortic aneurysm surgery with constant 
ventilation).25  Also, the percent decrease in CO2 elimination correlated with the 
percent decrease in cardiac output similarly (slope=0.33, r2=0.84).25 The 
changes in PETCO2 and CO2 elimination following hemodynamic perturbation 
were parallel. These findings suggest that decrease in PETCO2 quantitatively 
reflect the decreases in CO2 elimination.25 
Increases in cardiac output and pulmonary blood flow result in better 
perfusion of the alveoli and a rise in PETCO2.23, 24 Consequently alveolar dead 
space is reduced as is (a-ET) C02. The decrease in (a-ET) PC02 is due to an 
increase in the alveolar C02 with a relatively unchanged arterial C02 
concentration, suggesting better excretion of C02 into the lungs. The improved 
C02 excretion is due to better perfusion of upper parts of the lung.24   Relationship 
between PETCO2 and pulmonary artery blood flow was studied during separation 
from cardiopulmonary bypass26 This showed that PETCO2 is a useful index of 
pulmonary blood flow. A PETCO2 greater than 30 mm Hg was invariably 
associated with a cardiac output more than 4 L/min or a cardiac index > 2 
L/min.26 Furthermore, when PETCO2 exceeded 34 mm Hg, pulmonary blood flow 
was more than 5 L/min (CI > 2.5 L).26 
Thus, under conditions of constant lung ventilation, PETCO2 monitoring 
can be used as a monitor of pulmonary blood flow.26-31   
Recently, using Fick's Principle, attempts were made to determine cardiac 
output non-invasively implementing periods of CO2 rebreathing during which CO2 
partial pressure of oxygenated mixed venous blood was obtained from the 
measured exponential rise of the PETCO2 value. In addition, oxygen uptake, 
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carbon dioxide elimination, end-tidal PCO2, oxygen saturation, and tidal volume 
were determined. The results are encouraging in patients with healthy lungs.32 
Whereas the results are controversial when the lungs are diseased.33 
BLOOD PRESSURE AND P (a-ET) C02 
A study of seven anaesthetized patients whose mean arterial pressure 
(MAP) was lowered from 67 mmHg to an average of 50 mmHg, showed that 
physiological dead space increased in all patients. The increase resulted from 
enlargement of both anatomical and physiological dead space especially the 
later.34 In a later study done by the same investigator it was shown that the 
increase in P (a-ET) CO2 correlated strongly with the decrease in pulmonary 
artery pressure (PAP). Since a fall in pulmonary artery pressure parallels a 
reduction in MAP, the same effect on P (a-Et) CO2 is seen with reductions in 
MAP. Hypovolemia by its effect on cardiac output, MAP and PAP can lead to 
increase in P (a-ET) CO2. 
P (a-ET) CO2 AND VENTILATION 
Normal spontaneous ventilation results in preferential distribution of 
ventilation to dependent areas in the upright, lateral, supine and prone 
positions.35Frose and Bryan found that unlike in patients breathing 
spontaneously, paralysis and mechanical ventilation leads to preferential 
displacement of the passive diaphragm in the non- dependent zones where  
airway pressure and perfusion are least thus leading to an increase in dead 
space.36It has been shown that anaesthesia leads to increase in the physiological 
dead space.37 
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Russell et al., studying the stability of arterial to end tidal CO2 gradients 
during post operative cardio- respiratory support found that though changing 
respiratory rate and FiO2 can change V/Q ratios a correlation could not be 
demonstrated with P (a-ET) CO2.38 
In a very early study Nunn et al., concluded that P (a-ET) CO2 was not 
related to tidal volume.39 
Ramer et al., measuring the EtCO2 during anaesthesia found no consistent 
correlation between P (a-ET) CO2 gradient and variation in ventilation.39 
 P (a-ET) CO2 AND ANAESTHESIA 
During anaesthesia, increased degrees of uneven ventilation / perfusion 
relationships can occur. It has been found that a considerable impairment of the 
lung function exists during anaesthesia. This is expressed by increase in Arterial 
to Alveolar CO2 difference.40 
This increased difference is attributed to various factors: 
(1) Partial collapse of the lungs during continuous controlled ventilation 
without intermittent deep breath.41 
(2) Arterial hypotension.41 
(3) High FiO2 leading to absorption atelectasis thus increasing shunt.41 
  (4) Reduction in Functional residual capacity.42 
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Severinghaus et al., showed that major part of this difference is mainly due to 
grossly reduced perfusion in parts of lung that is by an increased in alveolar dead 
space.43 
Ramwell et al., found the difference between Arterial to End tidal CO2 to be 
significantly greater during anaesthesia44 
PaCO2-PETCO2 GRADIENT IN CABG 
R.Fletcher et al., studied 43 patients undergoing CABG surgery and found 
that the PaCO2-PETCO2 gradient varied widely.45, 46 The possible mechanisms 
they had attributed were  
(1) Decreased alveolar perfusion secondary to reduced cardiac output. 
(2) Altered patterns of pulmonary filling and emptying secondary to changes 
in functional residual capacity and the shape of the thoracic cavity brought 
about by sternotomy, sternal closure and extra corporeal circulation. 
(3) Increased intra pulmonary shunting by atelectasis, fluid overload and 
airway disease. 
Myles PS et al., studied PaCO2-PEtCO2 gradient continuously during 
cardiac surgery and found that there was a significant change in the gradient 
after cardio pulmonary bypass .47 
Opper SE et al., studied the effect of oxygenator and bypass flow pattern 
on PaCO2-PEtCO2 gradient and found that there was a trend for the gradient to 
increase in the post bypass period though it was not statistically significant. 
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48They also found that changes in mean arterial pressure, cardiac index, systemic 
vascular resistance and the duration of bypass did not influence the PaCO2- 
PEtCO2 gradient. 
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MATERIALS AND METHODOLOGY 
We did a preliminary study on ten patients who underwent elective CABG 
surgery. The PaCO2-EtCO2 gradient was calculated in pre bypass and post 
bypass period. 
The main purpose of this preliminary study was 
(1) To study and compare the relationship of Arterial CO2 - End tidal CO2 
gradient between the pre cardio pulmonary bypass and post cardio 
pulmonary bypass period. 
(2) To calculate the sample size required for the study. 
SAMPLE SIZE 
From the preliminary study, the sample size was calculated in order to derive 
statistically significant conclusions. 
The required sample size to show a significant change in PaCO2-EtCO2 gradient 
in pre cardio pulmonary and post cardio pulmonary bypass period was found to 
be 33 subjects with 80% power and at 5% level of significance. 
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THE MAIN STUDY 
INCLUSION CRITERIA 
All the patients undergoing elective CABG surgery. 
Patients willing to participate in the study. 
EXCLUSION CRITERIA 
Patients with severe pulmonary disease (FEV1=< 50% of predicted value). 
Patients not willing to participate in the study. 
METHOD OF STUDY 
All the patients undergoing elective CABG were visited pre operatively, the 
nature of the study explained to them and written consent taken. 
They were pre medicated with Tab. Diazepam 5 mg the night before 
surgery and Tab. Diazepam 7.5 mg 30 min before induction. They were shifted to 
the operating room with O2 mask 6 Liters/min in propped up position. Monitoring 
was established with pulse oximeter and ECG. A peripheral venous catheter was 
inserted, 500 ml of normal saline infusion started. Radial artery cannulation was 
done subsequently for invasive arterial pressure monitoring. 
After pre oxygenation with 100% O2, Anaesthesia was induced with Inj. 
Midazolam 0.05-0.1 mg/kg; Inj. Fentanyl 2-3 mcg/kg and   inhalational 
anaesthetic Sevoflurane 2-6 % conc (or) Isoflurane 2-3% conc. Patients were 
paralyzed with Vecuronium 0.1 mg/kg (or) Pancuronium 0.1 mg/kg and ventilated 
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for maximum of 5 minutes. Hypotension during this period was managed with 
small bolus doses of Inj. Phenylephrine 25-50 mcg. 
Endotracheal intubation was done and bilateral air entry checked. A 
central venous catheter was inserted through Right Internal jugular vein for 
central venous pressure monitoring and for administration of inotropes. A naso 
pharyngeal temperature probe was inserted to measure the temperature. As a 
protocol of this institution, adrenaline infusion was started at 0.1 mcg/kg up to 0.2 
mcg/kg in the post bypass period. 
Ventilation was maintained with                                
Datex Ohmeda 134 ventilator  
Mode   : Volume controlled mode with values set at 
Respiratory rate : 12/min 
Tidal volume  : 8 ml/kg 
Extra corporeal circulation was maintained with cardio pulmonary bypass 
machine. Fluid balance was maintained with central venous pressure monitoring. 
ESTIMATION OF PaCO2 AND ETCO2 
End tidal carbon dioxide was continuously monitored in all patients by a 
side stream infra red analyzer .The arterial blood PaCO2 measurement was 
calculated in a heparinised 2 ml syringe from the arterial line after discarding 5 ml 
of aspirate and made air tight before sending for analysis. 
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SAMPLING REGIMEN 
Measurements were made at four stages during surgery. 
1. 15 min after intubation (to allow time for sufficient equilibration). 
2. 5 min after sternotomy with the sternum fully retracted, before cannulation 
of the heart. 
3. 5 min after Cardio pulmonary bypass, with the heart decannulated and the 
sternum is fully retracted. 
4. 5 min after sternal closure. 
 
PARAMETERS MEASURED 
Hemodynamic parameters: 
Heart rate (beats/min) 
     Mean arterial pressure (mmHg) 
     Central venous pressure (mmHg) 
 
Ventilatory parameters: 
    End tidal CO2 (mm Hg) 
    Peak inspiratory pressure (CmH2O) 
    Expiratory tidal volume/ Inspiratory tidal volume (ml) 
    PEEP (CmH2O) 
 
Arterial blood gas analysis: 
    FiO2 (%) 
    PaO2 (mmHg) 
    PaCO2 (mmHg) 
    PaCO2/FiO2 Ratio 
PaCO2- EtCO2 gradient 
Temperature (0 c) 
All the information were recorded in the proforma and analyzed with the help of 
CMC statistician. 
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Figure 2: Distribution of weight 
 
                    
 
Figure 1: Distribution of Age
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Thirty three patients who underwent elective Coronary Artery Bypass Grafting 
surgery were included in the study. 
 
 
Age and weight Distribution 
The age and weight distribution are displayed in figure1 and 2 
respectively. The age distribution is between 30 and 72years.out of 33 patients 
seven patients were <=50 years and 26 were above 50 years.The weight 
distribution is between 43 and 83kgs. 
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Figure 3: SEX DISTRIBUTION 
 
 
 
 
 
 
 
Figure 4: SMOKING STATUS DISTRIBUTION 
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Sex distribution which is shown in figure 3 shows that out of 33 patients 
90.91% (30) were males and the remaining 9.09% (3) were females. 
 
 The smoking status distribution is displayed in figure 4 which is showing 
out of 33 patients 54.55 %( 18) were smokers.      
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Table 1: PaCO2-EtCO2 gradients in pre cardio pulmonary bypass and post 
cardio pulmonary bypass period 
PaCO2-EtCO2 gdt Pre- CPB Post-CPB 
Mean          4.5667         8.1985 
Standard deviation        1.36997         3.36144 
Standard error mean         238.48          .58515 
 
 
 
Table 2: PaCO2-EtCO2 gradient difference  
PaCO2-
EtCO2 gdt 
difference 
Mean Standard deviation 
Standard 
error 
mean 
“t” Significance 
  
-3.63182 
 
3.12149 
 
.54338 
 
-6.684
 
.000 
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The PaCO- EtCO2 gradients in pre cardiopulmonary bypass and post 
cardio pulmonary bypass period and the difference are shown in table 1 & 2 
respectively. The mean pre cardio pulmonary bypass (CP Bypass)  PaCO2 – 
EtCO2  gradient  was 4.5667 and the mean post CP Bypass PaCO2 – EtCO2  
gradient was 8.1985.There is statistically significant (p=.000) increase in the 
gradient (mean of 3.6318) after cardio pulmonary bypass using paired “t” test. 
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Table 3: PaCO2 in pre and post cardio pulmonary bypass period 
PaCO2 Pre-CPB Post-CPB 
Mean 35.7152 42.2758 
Standard deviation 4.08663 5.06446 
Standard error 
mean .71139 .88161 
 
 
 
 
Table 4: PaCO2 difference  
PaCO2 
difference 
Mean Standard 
deviation 
Standard 
error mean 
“t” Significance
  
-6.56061 
 
3.80143 
 
.66174 
 
-9.914
 
.000 
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Table 3 & 4 shows PaCO2 in pre cardiopulmonary bypass and post cardio 
pulmonary bypass period and the difference respectively. The mean pre CP 
Bypass PaCO2 was 35.7152 and the mean post CP Bypass PaCO2 was 42.2758. 
There is a statistically significant (p=.000) increase in PaCO2 after cardio 
pulmonary bypass (mean of 6.5606). 
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Table5: EtCO2 in pre and post cardio pulmonary bypass period 
EtCO2 Pre-CPB Post-CPB 
Mean 31.2424 34.1364 
Standard deviation 3.92134 3.85331 
Standard error 
mean .68262 .67078 
 
 
 
 
Table 6: EtCO2 difference 
EtCO2 
difference Mean 
Standard 
deviation 
Standard 
error mean “t” Significance 
 -2.89394 3.96027 .68939 -4.198 .000 
 
 
 
 
 
 
 
34
 
Table 5 & 6 shows EtCO2 in pre cardiopulmonary bypass and post cardio 
pulmonary bypass period and the difference respectively. . The mean pre CP 
Bypass EtCO2 was 31.2424 and the mean post CP Bypass EtCO2 was 34.1364. 
There is a statistically significant (p=.000) increase in EtCO2 after cardio 
pulmonary bypass (mean of 2.8939). 
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Table 7: Heart rate in pre and post cardio pulmonary bypass period 
Heart rate Pre CPB Post CPB 
Mean 74.3636 95.7727 
Standard deviation 15.43397 12.97900 
Standard error 
mean 2.68671 2.25935 
 
 
 
 
Table 8: Heart rate difference  
Heart rate 
difference Mean 
Standard 
deviation 
Standard 
error 
mean 
“t” Significance 
 -2.14091E1 17.00710 2.96056 -7.231 .000 
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Mean Heart rate in pre and post cardio pulmonary bypass periods are 
shown in tables 7 &8 respectively. . The mean pre CP Bypass heart rate was 
74.3636 and the mean post CP Bypass heart rate was 95.7727. There is a 
statistically significant (p=.000) increase in the heart rate after cardio pulmonary 
bypass (mean of 2.1409). 
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Table 9: Mean Arterial Pressure in Pre and Post cardio pulmonary bypass 
period. 
Mean Arterial Pressure Pre-CPB Post-CPB 
Mean 72.1364 65.6667 
Standard deviation 8.63882 6.92332 
Standard error mean 1.50383 1.20519 
 
 
 
 
Table 10: Mean Arterial Pressure difference. 
Mean Arterial 
Pressure 
difference 
Mean Standard deviation 
Standard 
error mean “t” Significance
 6.46970 9.65655 1.68099 3.849 .001 
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There is a statistically significant (p=.001) decrease in mean arterial 
pressure (mean of 6.469) following cardio pulmonary bypass. (Tables 9 & 10). 
The mean pre CP Bypass mean arterial pressure was 72.1364 and the mean 
post CP Bypass mean arterial pressure was 65.6667. 
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Table 11: Central Venous Pressure in Pre and Post cardio pulmonary 
bypass period. 
Central Venous Pressure Pre-CPB Post-CPB 
Mean 4.6061 5.0000 
Standard deviation 1.93147 2.59507 
Standard error mean .33623 .45174 
 
 
 
 
Table 12 : Central Venus Pressure Différence.  
Central 
Venous 
Pressure 
difference 
Mean Standard deviation
Standard 
error 
mean 
“t” Significance 
 -.39394 2.46145 .42848 -.919 .365 
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There is no statistically significant change in Central Venous Pressure in 
the post cardio pulmonary bypass period compared to the pre bypass values. 
(Tables 11& 12).The mean pre CP Bypass central venous pressure was 4.6061 
and the mean post CP Bypass central venous pressure was 5.0000. 
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Table 13: Peak Inspiratory Pressure in Pre and Post cardio pulmonary 
bypass period. 
Peak Inspiratory pressure Pre-CPB Post-CPB 
Mean 13.4545 13.5606 
Standard deviation 2.29593 2.48671 
Standard error mean .39967 .43288 
 
 
 
Table 14: Peak Inspiratory pressure difference 
Peak 
Inspiratory 
pressure 
difference 
Mean Standard deviation
Standard 
error 
mean 
“t” Significance 
 -.10606 1.73546 .30211 -.351 .728 
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There is no statistically significant change in Peak inspiratory Pressure in 
the post cardio pulmonary bypass period compared to the pre bypass values. 
(Tables 13& 14). The mean pre CP Bypass mean peak inspiratory pressure was 
13.4545 and the mean post CP Bypass peak inspiratory pressure was 13.5606. 
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Table 15: PaO2/ FiO2 Ratio in Pre and Post cardio pulmonary bypass period. 
PaO2/FiO2 Ratio Pre-CPB Post-CPB 
Mean 404.7455 376.1939 
Standard deviation 67.15693 91.49615 
Standard error mean 11.69052 15.92744 
 
 
 
 
 
Table 16: PaO2/FiO2 Ratio difference 
PaO2/FiO2 
Ratio 
difference 
Mean Standard deviation
Standard 
error mean “t” Significance 
 28.55152 83.83542 14.59387 1.956 .059 
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There is no statistically significant change in PaO2/ FiO2 ratio in the post 
cardio pulmonary bypass period compared to the pre bypass values.  (Tables 
15& 16).  The mean pre CP Bypass PaO2/FiO2 ratio was 404.7455 and the mean 
post CP Bypass PaO2/FiO2 ratio was 376.1939. 
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Table 17: Temperature in Pre and Post cardio pulmonary bypass period. 
Temperature Pre-CPB Post-CPB 
Mean 35.8515 36.2758 
Standard deviation .55783 .54703 
Standard error 
mean .09710 .09523 
  
 
 
 
 
Table 18: Temperature difference 
Temperature 
difference Mean 
Standard 
deviation 
Standard 
error 
mean 
“t” Significance 
 -.42424 .60443 .10522 -4.032 .000 
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Mean temperature in pre and post cardio pulmonary bypass are shown in 
tables 17 & 18.) The mean pre cp bypass temperature was 35.8515 and the 
mean post CP Bypass temperature was 36.2758. There is a statistically 
significant (p=.000) increase in temperature after CP Bypass (mean of .424). 
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Table 19: Correlation between PaCO2-EtCO2 gradient differences with other 
variables. 
 Pearson correlation Significance 
Heart rate difference -.019 .916 
Mean Arterial Pressure 
difference .148 .411 
Central Venous Pressure 
difference -.046 .799 
Peak Inspiratory Pressure 
difference .242 .174 
PaO2/ FiO2 Ratio difference .073 .688 
Temperature difference -.333 .058 
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Table 19 shows the correlation between PaCO2-EtCO2 gradient difference 
(Pre cardio pulmonary bypass _ Post cardio pulmonary bypass period) and Mean 
Heart rate difference, Mean arterial pressure difference, Central venous pressure 
difference, Peak inspiratory pressure difference, PaO2/ FiO2 Ratio difference and 
Temperature difference. There is no statistically significant correlation between 
any of the variables. 
PaCO2-EtCO2 gradient in smokers was 8.47 and in non smokers it was 
8.07. 
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DISCUSSION 
  It is known that the difference between PaCO2 and EtCO2is about 2-5 
mmHg even in normal individuals.1-5   It was postulated that the gradient between 
PaCO2 and EtCO2 varies widely during open-heart surgery especially before and 
after the cardio pulmonary bypass (CP Bypass) period due to various 
factors.45,46We were interested in studying if a change in the PaCO2-EtCO2 
gradient takes place in the post-bypass period during CABG surgery, and if it 
takes place, to quantify the magnitude of the change in the gradient and try to 
identify any factor affecting this gradient. 
  On studying 33 patients, one of the major positive observations was the 
increase in PaCO2-PEtCO2 gradient in the post cardio-pulmonary bypass period 
compared to pre bypass period. This increase in gradient is from as small as 0.6 
to a maximum of 15.7 with mean of 3.6. 
Even though both the absolute values of PaCO2 and EtCO2 increased in 
the post bypass period significantly, the magnitude of PaCO2 rise is more than 
that of EtCO2; thus resulting in a greater gradient. 
 While trying to identify the causative or contributory factors that caused a 
greater increase in PaCO2 over EtCO2, this study was able to identify one definite 
factor.  
This is the body temperature of the patient which increased significantly in 
the post-cardiopulmonary bypass period compared to the pre bypass period. This 
statistically significant increase in the temperature had a positive correlation with 
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the increase in the gradient. From the time the patient arrives in the efficiently air 
conditioned operating room, till the time the patient is hooked onto the bypass 
machine, there is a gradual drop in body temperature; mainly because, 
deliberately, no active warming of the patient is performed. Before coming-off CP 
Bypass, active rewarming of the patient’s blood is instituted to such an extent that 
the temperature very often overshoots above normal. Large increase in carbon 
dioxide production due to increase in temperature during rewarming most likely 
affects this increase in the PaCO2- EtCO2 gradient in the post cardio pulmonary 
bypass period. 
The other major factors which could be responsible for this increase in the 
gradient are the following, which are specific to the post CP Bypass period and 
are brought on by a combination of events that occur during CP Bypass. 
(1) Increase in the dead space due to decrease in cardiac output. 
(2) Increase in intra pulmonary shunting because of micro (or) 
macroatelectasis. 
(3) Interstitial fluid accumulation in the lungs 
All the above factors could interfere with or have an impact on the gas exchange 
in the alveoli.49    
1) Increase In Dead Space Due To Decrease In Cardiac Output 
Cardiac output was not directly measured in this study; but the statistically 
significant decrease in the mean arterial blood (MAP) pressure recorded in 
this study does probably reflect decrease in cardiac output. The 
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myocardium does suffer some insult during the CP Bypass period to result 
in the decrease in MAP in the post CPB period. So, though there was no 
statistically significant correlation between decrease in MAP and the 
increase in the PaCO2 and PEtCO2 gradient, the drop in MAP (statistically 
significant) probably contributed to the increase in dead space and its 
effect on the CO2 gradient. Additionally all patients were started on 
inotropic support (Inj.Adrenaline 0.1 mcg/kg/min) during weaning from 
bypass as is our protocol in our institution. This could have caused some 
element of pulmonary vasoconstriction which also could have a role in the 
increase in dead space. 54 
The increase in CO2 production during rewarming which induces a rise in 
PaCO2 does not result in the same increase in ETCO2 because probably 
the above-mentioned increase in dead space affects CO2 exchange. 
2) Increase In Intra Pulmonary Shunting Because Of Micro (Or) 
Macroatelectasis  
It was believed that atelectasis, whether micro or macro could be a very 
important factor responsible for the increase in CO2 gradient; but this 
study could not demonstrate any evidence in support of this surmise. In 
fact, there was no statistically significant difference in the PaO2-FiO2 ratio 
between the pre and post bypass period. Also, there was no significant 
change in the peak airway pressure detected in the post CP Bypass 
period. Any presence of significant atelectasis would have resulted in 
decrease in PaO2/FiO2 ratio and increase in the peak airway pressure.  
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If there are varying degrees of atelectasis there can be a slow upstroke of 
Phase II of the capnogram. If there was someway of measuring the speed 
of the upstroke in Phase II, the presence or absence of atelectasis could 
have been confirmed.52 
(3) Interstitial Fluid Accumulation In The Lungs 
Increased interstitial fluid in the lungs may be an expected accompaniment 
of CP Bypass. The presence of this feature can explain the increased CO2 
gradient. Once again we failed to show any evidence like increased peak 
airway pressure or an increased PaO2/FIO2 ratio following CP Bypass in 
this study to suggest that increased interstitial edema was the causative 
factor. 
R.Fletcher et al did a similar study in 43 patients undergoing CABG 
surgery. They found that the PaCO2-PETCO2 gradient varied widely.45, 46 
Although there were no significant change pre and post CP Bypass period, there 
were, however, some moderate individual changes. The possible mechanisms 
they have attributed were  
(1) Decreased alveolar perfusion secondary to reduced cardiac output. 
(2) Altered patterns of pulmonary filling and emptying secondary to changes in 
functional residual capacity and the shape of the thoracic cavity brought 
about by sternotomy, sterna closure and extra corporeal circulation. 
(3) Increased intra pulmonary shunting by atelectasis, fluid overload and 
airway disease. 
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We applied the Pearson test of correlation to the increase in PaCO2-
EtCO2 gradient with the a few other parameters like heart rate, central venous 
pressure, peak inspiratory pressure etc measured in pre cardio pulmonary 
bypass and post cardio pulmonary bypass periods.  
We found that though there was a statistically significant increase in heart 
rate in the post cardio pulmonary bypass period compared to the pre bypass 
value, there was no significant correlation with the increase in PaCO2-EtCO2 
gradient in post cardio pulmonary bypass period. This increase in heart rate is 
probably due to the inotrope (adrenaline) administered in the immediate post 
bypass period. 
When we looked at Central Venous pressure and Peak inspiratory 
pressure in the pre and post cardio pulmonary bypass period we could not find 
any significant change which correlated with the increase in the PaCO2- EtCO2 
gradient. 
In our study, surprisingly and contrary to our expectations we could not 
find any correlation between the smoking status of the subject and the increase in 
PaCO2-EtCO2 gradient. This may be because we had excluded patients with 
significant COPD from this study.         
Since the PaCO2 – EtCO2 gradient varies in the post cardio pulmonary 
bypass period; it is not advisable to depend only on the continuous EtCO2 value 
to determine the adequacy of ventilation. The ventilatory parameters that may 
have been employed in the pre bypass period may not result in the same arterial 
carbon dioxide in the post bypass period if only the EtCO2 is used to determine 
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the ventilatory adequacy. It is advisable to corroborate with the arterial blood gas 
estimation to determine whether ventilator settings may have to be altered to 
ensure adequacy of ventilation. This is particularly important when you wish to 
avoid respiratory acidosis induced worsening of pulmonary hypertension in the 
post CP Bypass period. 
It would be interesting to apply the study in children with congenital heart 
disease coming for correction under CP Bypass and also in adults with 
pulmonary hypertension coming for valvular heart surgery; to see what happens 
to the PaCO2 – EtCO2 gradient. 
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CONCLUSION 
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CONCLUSION 
This study has demonstrated that there is an increase in the PaCO2/EtCO2 
gradient in the post CP Bypass period as compared to the pre CP Bypass time. 
The increase in the body temperature during weaning from CP Bypass correlates 
with the increase in gradient. The increased CO2 production results in an increase 
in PaCO2; but this does not result in a parallel increase in EtCO2 probably 
because of the increase in dead space induced by decrease in cardiac output in 
the post CP Bypass period. The occurrence of increased CO2 gradient in the post 
CP Bypass period suggests that we should corroborate ETCO2 monitoring with 
arterial blood gas estimation to see the adequacy of ventilation when fixing 
ventilator settings to avoid possible respiratory acidosis. 
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APPENDIX 
 
PATIENT INFORMATION SHEET 
We, from the Department of Anesthesia in coordination with the Dept.of 
Cardiothoracic surgery in CMC Vellore, are conducting an observational study in 
patients undergoing elective CABG(Coronary Artery Bypass Grafting) with 
assistance of a heart lung machine. 
As you are enrolled in the above mentioned study, I would like you to have 
some information regarding the study conducted. 
            As you might already be knowing from your doctor, CABG is the surgery 
done for patients suffering from heart attack which is nothing but blockage of the 
blood vessels supplying the heart causing heart muscle death. 
            In this surgery, the blocked vessels are bypassed with healthy vessels 
from elsewhere. During this surgery heart is completely stopped and blood 
circulation is maintained using a heart lung machine. This surgery is done under 
general anesthesia and you will be ventilated with a small tube through your 
windpipe. During anesthesia to know the adequacy of  gas  exchange we need to 
monitor carbon dioxide content in your blood and exhaled gas.  
           Normally the carbon dioxide content in the arterial blood will be 5mm of 
mercury less than the exhaled gas. But during CABG the difference between 
arterial and exhaled carbon dioxide varies widely because of using heart lung 
machine, artificial ventilation and various other factors. 
            In this study, we are looking at the variations of the difference between 
arterial and exhaled carbon dioxide in the pre and post cardiopulmonary bypass 
period, to find out the factors responsible for the variation and to take necessary 
steps to reduce this variation. 
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          If you volunteer for this study, during surgery we will take 2 ml of blood 
from your artery at 4 timed intervals and your exhaled gases will be analyzed for 
carbon dioxide.  However there will be neither extra cost nor momentary benefit 
to you. Also there will be no discomfort to you as you will be under anaesthesia. 
There will be a senior anaesthetist supervising this study and you will be 
monitored continuously. 
         You will have to understand that your participation in the study is voluntary 
and that you are free to withdraw at any time, without giving any reason, without 
your medical care or legal rights being affected. 
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Informed Consent form to participate in a clinical trial 
Study Title: To study the relationship of arterial CO2 to End tidal CO2 in the 
pre cardio- pulmonary bypass and post Cardio- pulmonary bypass period                   
 
Study Number:                               Subject’s Name: ________ 
Date of Birth / Age:_______ 
(i) I confirm that I have read and understood the information sheet dated 
_________ for the above study and have had the opportunity to ask questions. [y] 
(ii) I understand that my participation in the study is voluntary and that I am 
free to withdraw at any time, without giving any reason, without my medical care 
or legal rights being affected. [y] 
 (iii) I understand that the Sponsor of the clinical trial, others working on the 
Sponsor’s behalf, the Ethics Committee and the regulatory authorities will not 
need my permission to look at my health records both in respect of the current 
study and any further research that may be conducted in relation to it, even if I 
withdraw from the trial. I agree to this access. However, I understand that my 
identity will not be revealed in any information released to third parties or 
published. [y] 
(iv) I agree not to restrict the use of any data or results that arise from this study 
provided such a use is only for scientific purpose(s) [y] 
(v) I agree to take part in the above study. [y] 
Signature (or Thumb impression) of the Subject: _____________ 
Date: _____/_____/______ 
Signatory’s Name: _________________________________ 
 
Signature of the Investigator: ________________________ 
Date: _____/_____/______ 
Study Investigator’s Name: _________________________ 
 
Signature of the Witness: ___________________________ 
Date:_____/_____/_______ 
Name of the Witness: ______________________________ 
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PROFORMA 
 
NAME      : 
AGE      :      yrs 
SEX      : M / F 
HOSPITAL NUMBER   : 
HT      :      cms            
WT      :      kg 
ASA GRADE     : 
SMOKING STATUS   : Y / N 
PROPOSED SURGERY   : 
DURATION OF CPB   :           Hrs 
INOTROPE     : Y / N 
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PREBYPASS  PERIOD POST BYPASS PERIOD  
PARAMETERS 
15 min post 
intubation 
5 min post 
sternotomy 
5 min 
post 
CBP 
5 min 
poststernal 
closure 
HR(beats/min)     
MAP(mm/hg)     
CVP(mm/hg)     
Peak ins pr/ Mean 
pr (CmH2O)     
EtCO2(mm/hg)     
FiO2 (%)     
PaO2(mm/hg)     
P/F RATIO     
PaCO2(mm/hg)     
PaCO2-EtCO2 gdt     
Temp(0c)     
Min 
ventilation(L/Min)           
Tidal volume - 
Insp/Exp(ml)     
PEEP (Cm H20)     
 
 
S.NO HOS.NO 
 
AGE SEX WT 
 
SM            HR(BEATS/MIN)    
              
MAP(MM/HG)                   CVP(MM/HG)    
PEAK/MEAN INSP 
PR(CmH2O) 
               PRE 
         
POST         PRE 
       
POST 
        
PRE        POST            PRE             POST 
1 166365D 65 M 64 N 71 77 72 71 60 90 66 64 9 4 11 11 12 16 13 17
2 846976C 50 M 80 Y 94 79 91 96 62 88 69 75 7 6 7 10 17 22 19 22
3 185679D 50 M 68 Y 69 79 129 121 65 78 62 66 4 1 2 4 13 12 13 16
4 173064D 59 M 40 Y 74 75 93 98 72 75 50 52 1 3 1 3 8 8 8 10
5 219250D 56 M 79 N 115 92 85 96 54 72 55 58 2 2 8 9 8 13 14 17
6 193760D 41 M 72 N 56 50 86 93 68 82 68 67 5 5 1 2 17 16 12 17
7 696761C 70 M 67 N 50 54 102 92 62 80 68 58 5 6 5 8 14 16 12 13
8 187982D 65 M 60 Y 78 72 120 124 70 77 63 60 9 6 10 11 16 14 12 13
9 209595D 57 M 57 N 61 65 108 105 72 85 60 86 8 2 2 3 11 13 11 11
10 305723C 65 M 82 Y 59 57 59 72 53 65 57 59 7 3 3 4 15 16 14 16
11 165368A 52 M 55 N 81 77 93 93 55 73 62 66 4 8 8 10 14 14 14 14
12 414531C 62 M 57 N 57 67 98 97 64 78 74 69 3 2 4 3 11 12 12 14
13 657564A 54 M 58 Y 57 72 82 87 68 78 66 59 6 2 6 4 11 11 9 11
14 175489D 59 M 74 Y 61 65 80 89 62 79 70 75 5 0 0 1 14 15 13 13
15 228043D 42 M 76 Y 57 85 94 95 65 64 71 62 7 4 6 6 17 16 14 16
16 226886D 57 M 57 Y 75 78 94 98 79 85 73 78 9 7 5 6 14 13 17 18
17 178432D 53 M 79 N 85 95 108 114 70 72 60 63 3 0 6 7 16 15 15 20
18 191577D 55 M 54 Y 106 118 119 123 68 82 62 60 7 3 3 3 10 12 9 11
19 209666D 72 M 61 Y 72 75 104 105 87 78 97 72 4 1 5 5 12 12 12 14
20 222839D 66 M 73 N 78 85 100 97 66 82 56 58 11 5 5 1 12 11 11 11
21 233852D 30 M 59 Y 75 78 91 84 73 63 74 75 3 1 3 4 13 14 12 13
22 430915C 58 M 53 Y 86 91 95 96 71 59 59 77 7 1 2 4 11 11 11 12
23 227457d 67 M 83 N 62 67 113 109 60 70 65 68 7 2 5 5 16 11 13 13
24 229080D 63 M 55 N 52 54 100 104 67 83 58 66 4 5 6 6 12 13 12 13
25 239742D 57 M 70 N 89 84 98 90 90 80 67 70 4 2 3 5 13 12 13 13
26 233149D 53 M 60 N 84 95 99 96 83 93 75 59 4 3 5 6 11 12 10 11
27 819102C 59 M 70 Y 78 77 100 96 54 65 66 72 4 6 4 5 16 16 12 15
28 011465D 50 M 76 Y 104 91 94 93 111 86 63 57 8 4 5 6 15 15 15 16
29 240240D 70 M 62 Y 53 52 69 83 66 73 70 66 8 8 9 3 14 12 14 17
30 008063D 47 F 50 N 86 104 95 87 86 60 71 57 2 3 2 1 13 12 12 14
31 976823B 53 F 68 Y 59 75 86 82 57 64 67 49 8 6 9 8 17 17 17 18
32 205160D 60 F 43 N 64 68 92 104 60 58 55 60 5 3 4 2 14 14 13 15
33 175924D 59 M 65 Y 54 53 85 97 74 70 76 76 6 4 5 4 15 10 11 12
MASTER DATA SHEET 
 
 
S.NO           ETCO2(MM/HG)                     PaCO2(MM/HG)                   EtCO2-PaCO2 GDT                  FiO2(%)             
         PRE       POST         PRE         POST         PRE       POST         PRE        POST   
1 29 26 27 27 34.6 30.9 32.5 32.5 5.6 4.9 7.5 7.5 1 0.7 0.7 0.7   
2 32 26 35 33 37.1 31 41.1 38.3 5.1 5 6.1 5.3 0.7 0.7 0.7 0.7   
3 31 31 37 37 35.2 35.9 42.7 43.5 4.2 4.9 5.7 6.5 0.4 0.4 0.7 0.7   
4 35 37 37 43 42.7 44 47.5 52.4 7.7 7 10.5 9.4 1 1 0.5 0.5   
5 42 32 35 35 45.8 33.6 39.5 40.8 3.8 1.6 4.5 5.8 0.7 0.7 0.7 0.7   
6 29 32 36 34 34.4 35 49.4 46.7 5.4 3 13 12.7 0.7 0.7 0.7 0.7   
7 27 29 35 39 32.8 34.8 40.9 46.5 5.8 5.8 5.9 7.5 0.5 0.5 1 1   
8 27 26 35 34 33 32 40 39 5 6 5 5 1 0.7 1 0.7   
9 28 28 34 33 30.4 32.9 40.5 37.3 2.4 4.9 6.5 7.3 0.5 0.5 0.5 0.5   
10 23 23 32 32 27.1 27.2 40.2 39.7 4.1 4.2 8.2 7.2 0.45 0.45 1 0.45   
11 30 34 30 31 35.4 37.9 39.9 40.6 5.4 3.9 9.9 9.6 1 0.7 1 0.7   
12 28 28 33 34 32.8 32.5 43.2 44.2 4.8 4.5 10.2 10.2 0.7 0.7 0.8 0.8   
13 36 36 44 42 39.1 40.1 48.4 46.3 3.1 4.1 4.4 4.3 1 0.7 1 0.7   
14 35 31 33 38 39.9 35.5 39.5 44.6 4.9 4.6 6.5 6.6 1 0.5 1 0.5   
15 28 29 39 37 32.9 31.4 44.1 42.3 4.9 2.4 5.1 5.3 1 0.5 1 0.5   
16 32 33 35 34 39.3 40 49 48 7.3 7 14 14 0.8 0.6 0.5 0.5   
17 33 35 41 33 32.6 33 48 39.2 1.6 2 7 6.2 0.45 0.45 0.6 0.6   
18 39 41 40 41 43.6 42.2 50.2 51 4.6 2.2 10.2 10 1 1 0.7 0.7   
19 36 38 31 29 36.3 44.2 51.2 47.7 0.3 6.2 19.2 18.7 0.7 0.7 1 0.5   
20 25 27 33 28 29.1 31.3 38.5 33.2 4.1 4.3 5.5 5.2 0.7 0.7 1 0.7   
21 32 31 36 34 35.8 34.4 40.6 38.5 3.8 3.4 4.6 4.5 1 0.6 1 0.7   
22 36 38 43 38 40.5 41.2 54.8 46.2 4.5 3.2 11.8 8.2 1 0.7 1 1   
23 28 29 38 37 34 35 46.5 46.6 6 6 8.5 9.6 0.75 0.75 0.7 0.7   
24 28 29 28 29 30 33.1 33.1 34.8 2 4.1 5.1 5.8 0.5 0.5 0.5 0.5   
25 30 31 32 34 35.8 36.5 40.8 48.4 5.8 5.5 8.8 14.4 0.7 0.7 1 0.7   
26 34 38 32 32 39.2 42.5 40 38.4 5.2 4.5 8 6.4 1 1 1 1   
27 33 32 35 34 37.7 36.1 41.5 42 4.7 4.1 6.5 8 0.6 0.6 1 0.6   
28 29 29 32 33 34.1 34 39.5 40.5 5.1 5 7.5 7.5 0.6 0.6 0.6 0.6   
29 27 28 29 29 31.8 30 36.1 38 4.8 2 7.1 7.8 1 0.6 1 0.6   
30 28 28 28 27 28.8 32.6 33.6 32.2 0.8 4.6 5.6 5.2 1 0.7 1 0.7   
31 34 35 33 33 41.8 42.9 46.8 50.7 7.9 7.9 13.8 17.7 0.6 0.6 0.6 0.6   
32 32 32 30 31 37.1 37.1 37.1 38.7 5.1 5.1 7.1 7.7 0.5 0.5 1 1   
33 30 34 34 36 35.8 39.9 41.5 43.2 5.8 5.9 7.5 7.2 0.5 0.5 1 0.5   
 
 
 
S.NO              PaO2(MM/HG)                            P/F RATIO  TEMP( °C)   PEEP(CmH2O) DRN(MIN)   
          PRE         POST          PRE        POST       PRE         POST  PRE POST    
1 430.2 316.6 337.5 267.4 430.2 452.2 482.1 382 36.5 37 37 37.1 0 2 2 2 160   
2 307.1 339 286.3 225.6 438 484.2 409 322.2 36.5 34.3 37.6 37 1 2 1 2 120   
3 199.7 111.9 167.3 161.3 499.2 279.7 239 230.4 36.6 36.3 36.5 36 2 2 4 4 130   
4 511.3 505.4 140.6 146.8 511.3 505.4 281.2 293.6 36.3 35.9 36.4 36.2 2 2 2 2 100   
5 308 330.9 339 299.3 215.6 472.7 484.2 427.5 35.9 35.5 36.7 36 1 2 2 2 120   
6 155.7 291.8 208.5 143.9 222.4 416.8 297.8 205.5 36.5 36 37.1 36.7 2 2 2 2 100   
7 198.8 190.3 444.8 369.4 397.6 380.6 444.8 369.4 35.7 36 36.8 36.6 2 2 2 2 70   
8 387.3 290 356 270.3 387.3 414.2 356 386.1 35.6 34.8 36.5 36.1 2 2 2 2 115   
9 283 225.6 156.5 309 566 450 313 618 35.8 35.5 37 37.9 2 2 2 2 105   
10 210 169.8 318.8 140.4 466.6 377.3 318.8 312 35.9 35.6 36 35.6 2 2 2 2 90   
11 391 341.3 486.1 309.1 391 487.5 486.1 441.5 36.5 36.7 37.6 36.3 2 1 2 2 160   
12 270.4 296.9 398.9 364.2 386.2 424.1 498.6 455.2 35.6 35.7 36.2 35.7 1 2 2 2 120   
13 487.9 330.3 339.9 261 487.9 471.8 339.9 372.8 35.7 35.8 36.8 36.3 2 1 2 2 150   
14 435.7 200 480.6 250 435.7 400 480.6 500 35.8 35.2 36.1 36.9 1 2 2 2 100   
15 380.7 140.5 379 84.2 380.7 281 379 168 36.5 36 37.2 37.5 1 2 2 2 140   
16 332 320 308 290 415 533.3 616 580 36.4 36.2 36.3 36.1 2 2 1 2 150   
17 126.2 130.1 160.8 148.4 280.4 289.1 268 247.3 36.6 36.1 36 36 1 0 1 1 95   
18 573 470 277 250 573 470 395.7 357.1 36 36.3 36.2 36.2 0 0 0 0 160   
19 248 251.5 424.9 129.8 354.2 359.2 424.9 259.6 36 35.3 35.9 35.5 0 0 1 1 150   
20 353.6 301.8 475.9 296.5 505 431.1 475.9 423.5 35.6 35.4 36 36.1 2 2 1 2 120   
21 439.1 146.6 422.8 288.7 439.1 244.3 422.8 412.4 35.8 35.7 36.4 36.2 0 0 0 0 100   
22 458.4 340.4 512 494 458.4 486.2 512 494 36.6 35.9 36 36 2 2 2 2 120   
23 249 230 157 129 332 306 224.2 184.2 35.9 35.8 36 36 0 0 0 0 120   
24 181.7 261.9 268.8 24.3 363.4 523.8 537.6 428.6 34 33.9 35 35.6 1 2 1 1 100   
25 223 234 313 260.3 318.5 334.2 313 371.8 34.6 35 35.2 36.2 0 0 0 0 120   
26 302.9 349.7 391.8 369.8 302.9 349.7 391.8 369.8 35.4 35 35.9 35.7 0 0 1 0 100   
27 251.4 267.9 432.7 185.7 419 446.5 432.7 309.5 36.4 36.2 36.6 36.4 1 2 2 2 80   
28 251.4 251.8 145.1 160 419 419.6 241.8 266.6 35.9 35.5 35.8 35.3 1 2 2 2 70   
29 464.2 268.7 406 296.6 464.2 447.8 406 494 36.4 36.2 36.6 35.9 1 1 2 2 80   
30 256 182.2 342.4 195.4 256 260.2 342.4 279.1 36.7 36.4 36.2 35.7 1 2 2 2 105   
31 244.6 229.3 215.3 149.5 407.6 382.1 358.3 249.1 35.9 35.7 36 35.7 1 1 2 2 90   
32 199.5 194.3 407.2 341.6 399 388.6 407.2 341.6 35.9 35.7 35.6 35.2 0 1 2 2 90   
33 186.9 223.9 412 142 373.8 447.8 412 284 36 36.1 36.5 36.8 1 2 2 2 100   
 
 
 
